Scholar Rock Holding Corporatio (SRRK) Financials
SRRK Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 250.7 million | 83.0 million |
2023-06-30 | 284.9 million | 82.4 million |
2023-03-31 | 314.7 million | 86.1 million |
2022-12-31 | 358.2 million | 97.9 million |
SRRK Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -32.3 million | 7.2 million |
2023-06-30 | -32.6 million | 6.8 million |
2023-03-31 | -43.1 million | 6.2 million |
2022-12-31 | -29.0 million | 6.2 million |
SRRK Net Income
No data available :(
SRRK Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 218.6 million | - | 13.5 million |
2023-06-30 | 248.7 million | 49.9 million | 15.5 million |
2023-03-31 | 275.3 million | 49.8 million | 17.7 million |
2022-12-31 | 315.4 million | 49.7 million | 19.7 million |
SRRK Shares Outstanding
SRRK Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 30.3 million | 13.3 million | - |
2023-06-30 | 41000 | 26.9 million | 12.2 million | - |
2023-03-31 | 30000 | 29.7 million | 10.8 million | - |
2022-12-31 | 117000 | 29.6 million | 10.8 million | - |
SRRK Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 708000 |
2023-06-30 | - | 2.6 million |
2023-03-31 | - | 2.5 million |
2022-12-31 | 33.2 million | 2.5 million |
SRRK
Price: $14.53
52 week price:
Earnings Per Share: -1.99 USD
P/E Ratio: -7.72
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 119758
Market Capitalization: 1.0 billion